Ve
Vesalius
Cambridge MAFounded 202125 employees
Private CapbiotechPrivateNeurology
Platform: Somatic Mosaic
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elrarasimod | VES-1309 | NDA/BLA | 2 | TNFα | Asthma | ||
| VES-5139 | VES-5139 | Phase 1/2 | 2 | JAK2 | SMACSU | ||
| VES-1701 | VES-1701 | Phase 1 | 1 | IL-13 | MDSHS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)